Future Medicine

THC Has Potential for Treating Agitation in Alzheimer’s Disease

In a crossover trial of 39 patients with Alzheimer’s disease, treatment with nabilone (a synthetic THC analog) was associated with significant improvement in agitation and, remarkably, cognition. Further studies should examine the effects of both THC and CBD in patients with Alzheimer’s disease because anxiety is common in dementia and may exacerbate agitation. 

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/2IH2BfX      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDTHC Has Potential for Treating Agitation in Alzheimer’s Disease
read more

Analyses of Cannabinoid Signaling in the Immune System Highlights Key Questions, Challenges, and Future Directions

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges

A meta-analysis concerning the role of cannabinoid signaling in immune system regulations revealed current therapeutic benefits, challenges for future research, and exciting new directions. Among the current research, cannabinoids have already been found to suppress inflammation associated with autoimmune diseases, especially in multiple sclerosis, rheumatoid arthritis, Type-1 Diabetes, and Crohn’s Disease. Future cannabis-based therapies aim to improve immune responses to organ donation, bone marrow transplants, and skin grafts. The analysis includes challenges facing future cannabis research such as potential side effects and legal status.  

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/31ArGR9      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDAnalyses of Cannabinoid Signaling in the Immune System Highlights Key Questions, Challenges, and Future Directions
read more

Variations in Genes Influences Cannabis’ Acute Effects on Behavior

CNR1 and FAAH variation and affective states induced by marijuana smoking

A recent study has revealed that variations within cannabinoid receptor 1 (CBR1) and fatty acid amide hydrolase (FAAH) influences cannabis’ acute effects on affect. Variations of CBR1 and FAAH are known to be associated with cannabis dependence. The current study now adds that the variations in genes also affect an individual’s behavior when ingesting cannabis. The results of this study provide useful information for understanding an individual’s motivation for marijuana use, as well as risks and associated behaviors.

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/31Ce9Za     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDVariations in Genes Influences Cannabis’ Acute Effects on Behavior
read more

Social Responsibility for the Cannabis Industry

With an emerging industry that has millions of dollars being fed into it, companies are trying to take social responsibility and operate with the public interest in mind. Things like this can narrow the gap of trust between industry, community, and policymakers, as well as fight stigma. https://nyp.st/2L4lKdp

Benjamin Caplan, MDSocial Responsibility for the Cannabis Industry
read more

Prospective analysis of safety and efficacy of medical cannabis in a large, unselected population of patients with cancer

In a study of 2,970 cancer patients, researchers determined that cannabis as a palliative treatment seems to be well tolerated, effective and a safe option to help patients cope with cancer-related symptoms.

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/2Fiid7B      inside the CED Foundation Archive

Benjamin Caplan, MDProspective analysis of safety and efficacy of medical cannabis in a large, unselected population of patients with cancer
read more

Recently Identified Mechanism of Chronic Stress-Induced Pain

Chronic Stress Is Associated with Pain Precipitation and Elevation in DeltaFosb Expression

Researchers have identified Delta-FosB, an osteosarcoma viral oncogene, as a useful molecular marker of sustained pain. The expression of Delta-FosB is significantly elevated by stress-induced pain, exposing its role in the adaptability of nerves. This study supports theories that Delta-FosB plays an important role in drug addiction, depression, and stress adaptation. The interaction between stress, depression, and pain is something that is not yet well-understood. But, as we learn more about cannabis-based medicine, many of the age-old questions about pain have become much clearer.

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/31A7Y86      inside the CED Foundation Archive

To explore related information, click the keywords below:

Tweet:

Benjamin Caplan, MDRecently Identified Mechanism of Chronic Stress-Induced Pain
read more

Pregnant women are using more cannabis over time

Statistics show that in the past 15 years, the number of pregnant women using marijuana, especially in their first trimester, has risen greatly. These numbers may be slightly skewed, but they show the importance of more research being done on the effect of cannabis on pregnant women. https://cnn.it/2WWQV1e

View this review (yellow link) or download:

This paper is also stored here:     http://bit.ly/2IwLxcp    inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDPregnant women are using more cannabis over time
read more

Home Grows vs Big Marijuana vs Governmental Oversight

In light of recent changes and discussion in NY and IL cannabis laws, the right to grow at home has been highly debated. Legislation and “big marijuana” are concerned with black market control, lab testing, and lost tax revenue; many of these concerns are blown out of proportion http://bit.ly/2WSbsUK

Benjamin Caplan, MDHome Grows vs Big Marijuana vs Governmental Oversight
read more

Safety and Efficacy of Medical Cannabis in Fibromyalgia

In a study of 367 patients, researchers investigated the safety and effectiveness of cannabis consumption to treat fibromyalgia symptoms. After treatment with cannabis, pain intensity (scale 0–10) reports reduced from a median of 9.0 to a median of 5.0. Interestingly, patients who had previously used cannabis were more likely to have treatment success, whereas patients who shared concerns about cannabis treatment were more likely to have treatment failure. A patient’s mindset can directly affect their treatment outcome.

At CED Clinic, we use the power of education to help patients feel comfortable and confident with their treatment plan.

View this review (yellow link) or download:

This paper is also stored here:     http://bit.ly/2WWLyz6    inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDSafety and Efficacy of Medical Cannabis in Fibromyalgia
read more

Profile of Dr Caplan, Dr Grinspoon, CED Clinic, and modern Medical Cannabis in Alcoholism & Drug Abuse Weekly

The esteemed medical periodical, Alcoholism & Drug Abuse Weekly, takes a closer look at modern medical cannabis with Dr Grinspoon and I. Our discussion brings an insider’s look at how the system operates, from clinic to dispensary, the dynamic changes we’ve already seen and highlights some of the changes to come. Included are The Role of Medicine, The Ethics of doctors in business, The Patient Experience, Physician’s Support, Growing the Plant, and a sit-down with a local dispensary.

View this review (yellow link) or download:

This paper is also stored here:     http://bit.ly/2Lc2H0R    inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDProfile of Dr Caplan, Dr Grinspoon, CED Clinic, and modern Medical Cannabis in Alcoholism & Drug Abuse Weekly
read more